In lung cancer, surgery is standard in early stages; for patients unfit for surgery or with limited cardiopulmonary reserve, precise beam methods such as proton and heavy ion therapy are strong options in Japan.
Proton therapy aims to protect healthy lung tissue around the tumor.
In advanced disease, multimodal planning combines immunotherapy and targeted agents.
Catheter-based regional approaches (IGT) may be considered as supportive options in selected advanced cases.
Stage and molecular profile (e.g. driver mutations) reshape the treatment map; your file is evaluated with these details.